Skip to content

The AABB Biotherapies Manual will be a first-of-its-kind reference that provides a structured guide across the full biotherapies lifecycle, from regulation and quality systems to manufacturing, testing, storage, and infusion.

Developed by leading experts from academia, industry, and regulatory agencies, it will deliver practical insights to strengthen programs and ensure safe, effective, high-quality product delivery.

Serving professionals across clinical, academic, and commercial settings, the Manual offers a foundational resource to navigate today’s rapidly expanding biotherapies field.

BiotherpiesManual1ed_FrontCover

Sections overview

  • Introduction
  • Section 1:  Regulatory considerations for manufacturing biotherapy products
  • Section 2:  Cellular Therapy Quality Oversight
  • Section 3:  Cell Processing Operations, Facilities and Equipment
  • Section 4: Cell Collection
  • Section 5:  Manufacturing Cellular Therapies
  • Section 6 :  Testing and Characterization of Cellular Therapies
  • Section 7: Laboratory Assays Commonly Use to Evaluate Cellular Therapies
  • Section 8: Product Storage, Issue, and Infusion

"We’ve gathered an outstanding group of leaders in the field to create what will be the go-to text on biotherapies — covering everything from regulations and quality to product development and ultimately patient administration."
David McKenna
David McKenna, MD, scientific & medical director at University of Minnesota and AABB Biotherapies Manual editor

Keep abreast of what's happening in the field of biotherapies with CellSource - AABB's monthly update on the latest biotherapies news.
CellSource-Wordmark (1)